IVY RX Review 2026: Separate Injection, Microdose, Melt, and MIC+B12 Options
By TotalCareMedical.com Health Team
Commercial and clinical disclosure: TotalCareMedical.com may earn compensation through the product page link. We reviewed a captured IVY RX homepage without enrolling, receiving care, verifying a pharmacy, testing a product, or confirming fulfillment or outcomes. This patient guide is educational and cannot replace a clinician’s judgment.
Separate-Lane Care Map
| Injection lane | Listed by IVY RX; full drug and dose details are not captured. |
|---|---|
| Microdose lane | Listed separately with a $77 homepage display. |
| Oral-melt lane | Its name does not establish its formula or approval status. |
| MIC + B12 lane | Separate $179 display; do not apply GLP-1 facts to it. |
| Product Page | Check the current IVY RX menu |
The easiest mistake on a large treatment menu is to let several product names blur into one “GLP-1 program.” IVY RX does not show one simple package. Its captured homepage places multiple offerings beside each other, while leaving the complete contents and applicant-level terms open.
Lane one: the GLP-1 Injection listing
IVY RX lists a GLP-1 Injection and displays “GLP-1” at $97. That number is only a seller-presented homepage display. It does not establish whether the amount is one-time or recurring, the total program cost, medication identity, formulation, dose, concentration, or what a given applicant would pay.
Do not use the word “injection” to fill those blanks. A reader comparing remote services can consult our compounded GLP-1 telehealth comparison, but a category comparison cannot identify what IVY RX may propose after clinical review.
Lane two: GLP-1 Microdose
The GLP-1 Microdose appears as a separate menu item with a $77 display. “Microdose” is a seller label, not a captured dosing instruction. The source does not state the medicine, amount, concentration, cadence, total cost, or applicant-specific price behind it.
Never merge the $77 figure with the $97 display. Neither number proves eligibility, includes every charge, or promises that a clinician will prescribe. For a broader explanation of a compounded-care pathway, see how compounded semaglutide telehealth works; it does not establish this offering’s ingredients or terms.
Lane three: GLP-1 Oral Melts
IVY RX separately names GLP-1 Oral Melts. The product name alone does not reveal a complete formulation, dose, concentration, evidence basis, approval status, or fulfillment arrangement. Nothing in the capture permits us to treat a melt as the injection or microdose offering in another form.
Anti-Nausea Tablets and GLP-1 Boost are also separate listings. Ozempic®, Mounjaro®, and Metformin appear as distinct named choices. Do not transfer pricing, dose, formulation, evidence, safety, approval, or delivery statements from one listing to another.
Lane four: MIC + B12 Injection
IVY RX displays MIC + B12 Injection at $179. Keep that number apart from both GLP-1 displays. The capture gives no cadence, complete ingredients, dose, concentration, total treatment cost, or individual quote. Most importantly, the compounded GLP-1 warning block summarized below should not be applied to MIC + B12.
Our compounded semaglutide cost guide may help with budgeting questions, but it cannot turn IVY RX’s displayed figures into complete prices.
One intake does not erase separate responsibilities
IVY RX says the process begins with a health questionnaire. A licensed medical provider or physician then reviews the information. If prescribed, IVY RX says medication is sent discreetly from an FDA-registered or partner pharmacy. IVY RX operates the customer-facing pathway, a clinician exercises prescribing discretion, a pharmacy handles dispensing, and a delivery party handles the shipment.
The seller promotes a free consultation, fast approval, no-insurance access, free discreet delivery, a five-minute assessment, and arrival in as little as two days. It says it has served more than 200,000 patients. Its FAQ describes affiliated doctors as board-certified and U.S.-licensed and says portal messaging is available. All are IVY RX representations, not independently verified guarantees for an applicant.
The compounding rule remains the same
Compounded drugs are not FDA approved, and FDA does not review compounded drugs for safety, effectiveness, or quality. A pharmacy’s FDA registration is not approval of a compounded drug. IVY RX’s FAQ claim that treatments come from pharmacies compliant with 503B/USP <797> standards is an unverified seller sourcing statement, not FDA review. The capture does not identify the eventual dispensing pharmacy.
No compound should be presented as generic, brand-equivalent, bioequivalent, interchangeable, substitutable, identical to, the same as, or made with the same active ingredient as an FDA-approved branded drug.
The captured GLP-1 warning belongs only to its source context
IVY RX’s compounded GLP-1 material warns about severe nausea or vomiting that can cause dehydration; kidney trouble; pancreatitis; acute gallbladder disease; hepatitis or jaundice; diabetic-retinopathy changes; severe gastrointestinal disease; hypoglycemia; increased heart rate; depression or suicidality changes; and serious hypersensitivity.
The source discusses thyroid C-cell tumors and says a personal or family history of medullary thyroid carcinoma or MEN2 is a contraindication. It notes rodent findings with uncertain human relevance. Trouble swallowing, hoarseness, a neck lump or swelling, and shortness of breath are listed as thyroid warning symptoms.
Interaction boundaries include alcohol, insulin, and insulin secretagogues such as sulfonylureas. Delayed gastric emptying may affect oral-medication absorption. The capture uses the exact wording “papillary hormone medication” and says timing may require discussion. Narrow-therapeutic-window medicines such as warfarin may need close monitoring.
IVY RX advises reviewing diabetes medicines, avoiding alcohol, using adequate contraception, and avoiding GLP-1 medication during pregnancy, attempts to become pregnant, or breastfeeding. It says to stop at least two months before planned pregnancy and to report kidney, liver, or pancreas history. This is not a full contraindication, interaction, eligibility, formula, or dosing guide.
Questions that belong beside each lane
Use written prepayment questions. Ask for the exact product, medication identity, complete formulation, dose, concentration, instructions, and eligibility basis. Request named-pharmacy details, the full price and cadence, cancellation and refund rules, autobill details, storage and cold-chain directions, and shipment-remedy terms. The capture does not establish those terms or provide independently verified outcome terms.
IVY RX displays a 4.7 rating, more than 6,000 reviews, and a customer story reporting a 46-pound loss in eight weeks. Those are seller-selected marketing claims, not proof of a likely result. No result is guaranteed.
Patient-centered conclusion
This menu may appeal to an adult who accepts remote assessment and is willing to compare written, lane-specific details. It is not for someone expecting automatic approval, one shared safety profile, an assured price, or emergency help. Give the clinician a complete list of prescriptions, nonprescription drugs, supplements, herbal products, alcohol use, allergies, and relevant history before any decision.
Seek prompt in-person help for troublesome effects. In an emergency, call 911 or go to the nearest emergency room. No webpage can determine suitability, and no seller display replaces individualized clinical care or order-specific documents.
FDA notice: Compounded drugs are not FDA approved, and FDA does not review compounded drugs for safety, effectiveness, or quality.